Join us for a deep dive into Anti-Xa assay testing for heparin and DOACs. This expert-led webinar explores clinical applications, lab best practices, and assay standardization. Ideal for lab professionals, clinicians, and pharmacists aiming to optimize anticoagulation therapy and improve patient outcomes. Register now for this valuable session on April 29th, 2025.
Ibex Medical Analytics’ inaugural Patient Insight Report on Cancer Diagnostics reveals widespread concerns about cancer diagnoses.
CLP’s Chris Wolski discusses the hows and whys of keeping kids engaged in science with Natalie Kuldell, executive director of BioBuilder.
After being declared eradicated in the U.S. in 2000, measles has been making a comeback in recent years—the current caseload equals the entire number of cases in 2023.
Read More
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.
Read More
In this episode of Clinical Lab Chat, CLP’s Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology.
Read More
The newly launched Cancer Screening Research Network (CSRN) will evaluate promising and emerging cancer screening technologies.
Read More
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read More
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read More
This research could help address challenges in misdiagnosis and treatment of patients, potentially reducing bleeding complication risks.
Read More
In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.
Read More
CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include using urine to identify breast cancer biomarkers; the distinctions between mammographies and liquid biopsies for cancer detection; and more.
Read More
Discover the latest insights on food allergies in the U.S. on Clinical Lab Chat! Join Chris Wolski, CLP’s Director of Business Intelligence, in a conversation with Jessica Murphy, MLS(ASCP)CM, from Thermo Fisher Scientific. They delve into:
The surge in food allergies among Americans and its causes.
The game-changing impact of home testing on allergy detection (and its challenges).
The crucial role of primary care doctors in allergy testing.
The promise of precise allergy testing for better patient care.
Why clinical labs remain vital for allergy diagnostics.
A glimpse into the future of allergy testing in the next 5-10 years. Don’t miss it!
XiFin has added new features and insights to its Lab Volume Index (LVI), with a deeper dive in the post-pandemic diagnostic landscape.
Read More
In its second annual Wage and Morale Survey, Lighthouse Lab Services found improvements in wages and satisfaction, but more can be done.
Read MoreLearn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Read More
Chris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today.
Read More
Chris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care.
Read More